ClearPoint Neuro, Inc. Common Stock
Veridion Score
Composite trend over time
Why is CLPT moving today?
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CLPT.
CLPT insider activity
ClearPoint Neuro, Inc. Common Stock
5 insiders bought in the last 90 days
Net selling: -$4.6M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-07-01 | Richards Timothy T. | Insider | buy | $17.84 | 222 | 87,544 | $4K | SEC Form 4 |
| 2026-07-06 | 2026-07-01 | FLETCHER R JOHN | Insider | buy | $17.84 | 662 | 131,011 | $12K | SEC Form 4 |
| 2026-07-02 | 2026-06-30 | STIGALL L. JEREMY | Insider | buy | $11.93 | 1,781 | 110,263 | $21K | SEC Form 4 |
| 2026-07-02 | 2026-06-30 | D'Alessandro Danilo | Insider | buy | $11.93 | 1,085 | 103,769 | $13K | SEC Form 4 |
| 2026-07-02 | 2026-06-30 | BURNETT JOSEPH | Insider | buy | $11.93 | 1,361 | 118,203 | $16K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 49 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCLPT contract awards, year to date.
Public federal awards linked to this ticker.
CLPT lobbying filings, year to date.
Registered lobbying filings matched to ClearPoint Neuro, Inc. Common Stock.